Somebody coined prejuvenation and it worked. The word can describe sensible sun protection, early treatment of a defined concern, or a conservative procedure chosen for a specific goal. It can also be an elegant way to sell intervention to someone who did not think they had a problem until the sentence was said out loud.
Prejuvenation is a category, not any one clinician’s position, and the category is what this piece is examining. Ava Shamban is a useful vantage point on it because she was publicly visible for the entire stretch in which the idea traveled from specialist vocabulary to beauty-counter default. She is a board-certified dermatologist, a long-time cosmetic physician, an author, a media educator and a clinical-trial investigator, and her career tracks the exact period when aesthetic dermatology moved out of a relatively private specialty and into mainstream beauty culture.
Prevention means something once the target is named
Sun protection prevents real UV damage. Treating acne early can limit real inflammation and its sequelae. Preventative Botox and preventative lasers demand a much more individualized conversation: what outcome is being prevented, what evidence supports starting at this specific age, what happens if the person simply waits.
A prevention claim gets stronger the moment the target, the evidence and the alternative are stated out loud. It gets weaker the moment start before you need it is the entire argument on offer.
The baseline moved and nobody announced it
There was a time when injectables and resurfacing were discussed far more quietly. Media physicians helped move those procedures into everyday vocabulary, which has real upside: someone considering a treatment can learn what it is called and what questions belong in a consultation before ever walking into an office.
Mainstream visibility carries a cost too. Once a treatment becomes culturally ordinary, the baseline shifts underneath the conversation. The question stops being do I want this and becomes when should I start, which is not a neutral change. It converts an optional cosmetic decision into something that feels like a schedule you are already behind on.
The invoice arrives later
Starting earlier usually means maintaining longer. A treatment begun in someone’s twenties can become a recurring expense stretched across decades if they like the result and want to keep it. That does not make early treatment wrong. It does make the annual cost and the appointment frequency part of informed planning, and it is the part least likely to come up in the room.
Before prevention turns into a standing schedule, price the whole ownership model — the maintenance invoice, not the opening charge.
A trial résumé should narrow a claim, not decorate one
A clinician who has run trials has watched a study tightly define its population, protocol and endpoints. Consumer marketing strips all of that away and keeps the conclusion.
Which is exactly why clinically tested and FDA cleared should not be allowed to float untethered: tested for what, cleared for which use, how large was the effect, who was included in the study that produced it. Research credibility does its best work when it narrows a public claim, not when it becomes one more badge stapled to a treatment page.
The career, and the single page describing it
Shamban’s current practice biography lists a magna cum laude degree from Harvard and a medical degree from Case Western Reserve University School of Medicine, prior service as an Assistant Clinical Professor at UCLA’s Geffen School of Medicine, and work as a principal investigator on clinical and FDA trials. Her practice has spanned medical and cosmetic dermatology for years, alongside a long-running role translating procedures for television and mainstream media.
That combination makes her a bridge across several versions of cosmetic medicine at once: the physician’s office, the research environment, and the beauty conversation most patients actually arrive from. It is also worth saying that the source below is the only one this profile has, and it is her practice’s own site. Every credential above comes from materials she controls. That is not an allegation of anything. It is a limit on how much weight any of it can carry, and a reader is entitled to know which it is.
Self-esteem belongs in the room without becoming the pitch
Shamban’s practice philosophy explicitly connects appearance and self-esteem, and cosmetic concerns genuinely can affect confidence. Dismissing that outright would be its own oversimplification.
The trouble starts the moment self-esteem is treated as an outcome a clinic can reliably manufacture, or the moment declining treatment is reframed as failing to invest in yourself. A good consultation holds both things at once: appearance genuinely matters to the patient, and it is still fair to ask what degree of change is realistic and whether they would want this without an approaching birthday or a comparison trend pushing from behind.
Doing nothing is a comparator, not a missing option
Aesthetic medicine loves comparing one procedure against another. The comparator that quietly goes missing is no procedure at all. What happens if you wait? Does the concern stay cosmetic and manageable on its own? Could sun protection or a different haircut meet the same goal without a recurring medical intervention attached?
Doing nothing for now was never anti-aesthetic. It is one of the options that keeps the whole decision voluntary. Shereene Idriss built a following on saying that out loud, which suggests the appetite for it was there the whole time.
What Shamban’s career helps explain is how cosmetic dermatology went ordinary — and why ordinary still needs boundaries. Prevention is strongest when the target is named, the evidence is proportional, and waiting stays genuinely on the table. Otherwise prejuvenation is a very polished way of putting optional medicine on a subscription plan nobody remembers agreeing to.
The only page I have
Editorial note: This profile is based on public professional and practice information checked August 8, 2026. It is not medical advice, a personal endorsement, or a claim of treatment experience.
Source file